Publications (154) Jose Miguel Rivera Caravaca publications

filter_list

2025

  1. Analysis of key proinflammatory mechanisms in cardiovascular pathology through stimulation with lipopolysaccharide and urban particulate matter in mouse atrial cardiomyocytes

    Environmental Toxicology and Pharmacology, Vol. 114

  2. Atrial fibrillation versus atrial myopathy in thrombogenesis: Two sides of the same coin?

    Trends in Cardiovascular Medicine

  3. Clinical and subclinical acute brain injury caused by invasive cardiovascular procedures

    Nature Reviews Cardiology, Vol. 22, Núm. 4, pp. 273-303

  4. Evaluating the Appropriate Use Criteria for Coronary Revascularization in Stable Ischemic Heart Disease Using Randomized Data From the ISCHEMIA Trial

    Circulation: Cardiovascular Quality and Outcomes, Vol. 18, Núm. 3, pp. e010849

  5. Poor clinical outcomes associated to multimorbidity, frailty and malnutrition in patients with atrial fibrillation

    Journal of Nutrition, Health and Aging, Vol. 29, Núm. 1

  6. The Neutrophil-to-Lymphocyte Ratio Is an Independent Inflammatory Biomarker for Adverse Events in Patients With Atrial Fibrillation: Insights From the Murcia AF Project II (MAFP-II) Cohort Study

    Clinical cardiology, Vol. 48, Núm. 2, pp. e70102

  7. The use of oral anticoagulation at the time of acute COVID-19 infection and subsequent development of long-COVID/post-acute sequelae of SARS-CoV-2 infection

    Journal of Thrombosis and Thrombolysis

2024

  1. Advances in the medical treatment and diagnosis of intracranial hemorrhage associated with oral anticoagulation

    Expert Review of Neurotherapeutics, Vol. 24, Núm. 9, pp. 913-928

  2. Dynamic assessment of CHA2DS2-VASc and HAS-BLED scores for predicting ischemic stroke and major bleeding in atrial fibrillation patients

    Revista Espanola de Cardiologia, Vol. 77, Núm. 10, pp. 835-842

  3. Endothelial activation, Cell-Cell Interactions, and Inflammatory Pathways in Postoperative Atrial Fibrillation Following Cardiac Surgery.

    Biomedical Journal, pp. 100821

  4. Impact of prior oral anticoagulation therapies on post-discharge outcomes after COVID-19: Results from a global federated health network analysis

    European Journal of Clinical Investigation, Vol. 54, Núm. 12

  5. Navigating the bleeding risk dilemma in patients with atrial fibrillation on therapy with direct-acting oral anticoagulants: Comparing the HAS-BLED vs. DOAC Score

    European Journal of Internal Medicine

  6. Patients with atrial fibrillation and common exclusion criteria from clinical trials are at high risk of clinical events: the Murcia AF Project II (MAFP-II) cohort study

    Internal and Emergency Medicine, Vol. 19, Núm. 7, pp. 1941-1948

  7. Relationship Between Severity of Ischemia and Coronary Artery Disease for Different Stress Test Modalities in the ISCHEMIA Trial

    Circulation: Cardiovascular Interventions, Vol. 17, Núm. 12, pp. e013743

2023

  1. Adverse Clinical Outcomes and Associated Predictors in Rivaroxaban-Treated Atrial Fibrillation Patients With Renal Impairment

    American Journal of Cardiology, Vol. 203, pp. 122-127

  2. Cerebrovascular, Cognitive and Cardiac Benefits of SGLT2 Inhibitors Therapy in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus: Results from a Global Federated Health Network Analysis

    Journal of Clinical Medicine, Vol. 12, Núm. 8

  3. Clinical implications of different types of dementia in patients with atrial fibrillation: Insights from a global federated health network analysis

    Clinical Cardiology, Vol. 46, Núm. 6, pp. 656-662

  4. Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry

    European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 9, Núm. 1, pp. 8-15

  5. Epilepsy-Heart Syndrome: Incidence and Clinical Outcomes of Cardiac Complications in patients with Epilepsy

    Current Problems in Cardiology, Vol. 48, Núm. 10

  6. High medium-term incidence of major cardiovascular events in discharged patients with unstable angina

    IJC Heart and Vasculature, Vol. 46